117 related articles for article (PubMed ID: 16901447)
1. Bone mineral status in pediatric outpatients on antiepileptic drug monotherapy.
Tekgul H; Serdaroglu G; Huseyinov A; Gökben S
J Child Neurol; 2006 May; 21(5):411-4. PubMed ID: 16901447
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of bone turnover in epileptic children using oxcarbazepine.
Cansu A; Yesilkaya E; Serdaroğlu A; Hirfanoğlu TL; Camurdan O; Gülbahar O; Gücüyener K; Cinaz P
Pediatr Neurol; 2008 Oct; 39(4):266-71. PubMed ID: 18805365
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
Chou IJ; Lin KL; Wang HS; Wang CJ
Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
[TBL] [Abstract][Full Text] [Related]
4. Adverse effects of antiepileptic drugs on bone mineral density.
Babayigit A; Dirik E; Bober E; Cakmakci H
Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic Drugs and Bone Health in Thai Children with Epilepsy.
Paticheep S; Chotipanich C; Khusiwilai K; Wichaporn A; Khongsaengdao S
J Med Assoc Thai; 2015 Jun; 98(6):535-41. PubMed ID: 26219156
[TBL] [Abstract][Full Text] [Related]
6. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
[TBL] [Abstract][Full Text] [Related]
7. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
Serin HM; Koç ZP; Temelli B; Esen İ
Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
[TBL] [Abstract][Full Text] [Related]
8. Effect of carbamazepine and valproate on bone mineral density.
Ecevit C; Aydoğan A; Kavakli T; Altinöz S
Pediatr Neurol; 2004 Oct; 31(4):279-82. PubMed ID: 15464641
[TBL] [Abstract][Full Text] [Related]
9. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy.
Tsukahara H; Kimura K; Todoroki Y; Ohshima Y; Hiraoka M; Shigematsu Y; Tsukahara Y; Miura M; Mayumi M
Pediatr Int; 2002 Jun; 44(3):247-53. PubMed ID: 11982890
[TBL] [Abstract][Full Text] [Related]
11. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of bone mineral density in children receiving antiepileptic drugs.
Akin R; Okutan V; Sarici U; Altunbas A; Gökçay E
Pediatr Neurol; 1998 Aug; 19(2):129-31. PubMed ID: 9744632
[TBL] [Abstract][Full Text] [Related]
13. BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy.
Lambrinoudaki I; Kaparos G; Armeni E; Alexandrou A; Damaskos C; Logothetis E; Creatsa M; Antoniou A; Kouskouni E; Triantafyllou N
Eur J Neurol; 2011 Jan; 18(1):93-8. PubMed ID: 20500803
[TBL] [Abstract][Full Text] [Related]
14. Effect of antiepileptic drugs on bone density in ambulatory patients.
Farhat G; Yamout B; Mikati MA; Demirjian S; Sawaya R; El-Hajj Fuleihan G
Neurology; 2002 May; 58(9):1348-53. PubMed ID: 12011279
[TBL] [Abstract][Full Text] [Related]
15. Bone health and vitamin D status in young epilepsy patients on valproate monotherapy.
Albaghdadi O; Alhalabi MS; Alourfi Z; Youssef LA
Clin Neurol Neurosurg; 2016 Jul; 146():52-6. PubMed ID: 27150607
[TBL] [Abstract][Full Text] [Related]
16. [Bone mineral density in children with long-term antiepileptic therapy].
Dimić M; Dimić A; Milosević Z; Vojinović J
Srp Arh Celok Lek; 2013; 141(5-6):329-32. PubMed ID: 23858802
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
Mintzer S; Boppana P; Toguri J; DeSantis A
Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
[TBL] [Abstract][Full Text] [Related]
18. Bone mineral density with lamotrigine monotherapy for epilepsy.
Sheth RD; Hermann BP
Pediatr Neurol; 2007 Oct; 37(4):250-4. PubMed ID: 17903668
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density in ambulatory children with epilepsy.
Yaghini O; Tonekaboni SH; Amir Shahkarami SM; Ahmad Abadi F; Shariat F; Abdollah Gorji F
Indian J Pediatr; 2015 Mar; 82(3):225-9. PubMed ID: 25106841
[TBL] [Abstract][Full Text] [Related]
20. Effect of long-term valproate monotherapy on bone mineral density in adults with epilepsy.
Triantafyllou N; Lambrinoudaki I; Armeni E; Evangelopoulos EM; Boufidou F; Antoniou A; Tsivgoulis G
J Neurol Sci; 2010 Mar; 290(1-2):131-4. PubMed ID: 20056251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
